Trademark: 97812874
Status Date
Tuesday, February 27, 2024
Filing Date
Monday, February 27, 2023
Published for Opposition
Tuesday, February 27, 2024
41 Educational services, namely, creating and developing web-based and in-person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets
9 Software as a Medical Device (SaMD), downloadable, for predicting blood analyte levels and adjusting infusion pump settings based on personalized data; Downloadable educational mobile applications featuring information and instruction on managing, treating and living with chronic disease; batteries; battery chargers
5 Infusion cartridges sold pre-filled with medication for medical use in the field of cardiovascular disease, diabetes, asthma, kidney disease, and cancer; Adhesive overlays in the nature of adhesive medical tape and adhesive bandages for use with infusion pumps and associated devices
35 Providing a trade-in program for drug delivery and chronic disease management devices; Pharmaceutical services, namely mail-order pharmacy services and processing online and telephone prescription orders in retail and central fill pharmacies featuring chronic disease management supplies, medications, drugs and other prescriptions
44 Interactive medical monitoring and alert services for reminding infusion pump users of medicinal dosage for medical treatment purposes in the nature of monitoring and managing chronic disease; Providing medical information to infusion pump users in the form of reports in the field of chronic disease management; Providing a website featuring general medical information related to chronic diseases, including advice on treatment options and chronic disease management; Providing online searchable medical databases in the field of chronic disease management for patients, their families, caregivers, and healthcare practitioners; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease
10 medical devices, namely, infusion and injection devices for administering drugs, and pouches and mounts used therewith; medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; medical apparatus for monitoring blood analyte levels; implantable subcutaneous drug delivery devices, sold empty in the nature of medical field injectors; on-body medical fluid injectors; chronic disease management devices, in the nature of medical sensors that are implanted or inserted into the human body used to continuously gather human biometric data for monitoring the concentration of analytes in the human body and also including accessories therefor, namely, receivers, sensor housings and sensor insertion devices sold as a unit; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor
42 Software-as-a-service (SAAS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels; Upgrading of computer software, namely, Software as a Medical Device (SaMD)
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 27, 2024
Published For Opposition
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2024
Approved For Pub - Principal Register
Jan 24, 2024
Examiner's Amendment Entered
Jan 24, 2024
Notification Of Examiners Amendment E-Mailed
Jan 24, 2024
Examiners Amendment E-Mailed
Jan 24, 2024
Examiners Amendment -Written
Jan 24, 2024
Previous Allowance Count Withdrawn
Dec 19, 2023
Withdrawn From Pub - Og Review Query
Dec 1, 2023
Approved For Pub - Principal Register
Nov 30, 2023
Teas/Email Correspondence Entered
Nov 30, 2023
Correspondence Received In Law Office
Nov 30, 2023
Teas Response To Office Action Received
Nov 29, 2023
Notification Of Non-Final Action E-Mailed
Nov 29, 2023
Non-Final Action E-Mailed
Nov 29, 2023
Non-Final Action Written
Nov 28, 2023
Assigned To Examiner
Mar 16, 2023
New Application Office Supplied Data Entered
Mar 2, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
